Halozyme Therapeutics Inc (NASDAQ:HALO)
| 9.51 Data as of Jul 29 |  +0.60 / +6.73%Today’s Change | 6.51 Today|||52-Week Range 18.18 | -36.56% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2010 | 2011 | 2012 | 2013 | |||
| Revenue and Income | Net Revenues | 13.6M | 56.1M | 42.3M | 54.8M | |
| Cost of Goods Sold | 985.3K | 257.8K | 1.1M | 6.2M | ||
| Depreciation And Amortization | 1.5M | 1.1M | 1.1M | 1.2M | ||
| Operating Expenses | Gross Income | 11.1M | 54.7M | 40.2M | 47.3M | |
| General Expenses | 63.3M | 74.6M | 93.8M | 127.8M | ||
| Research And Development | 50.6M | 57.6M | 69.0M | 95.4M | ||
| Total Operating Expenses | 65.8M | 75.9M | 96.0M | 135.2M | ||
| Non-Operating Expenses | Operating Income | -52.1M | -19.8M | -53.6M | -80.4M | |
| Extraordinary Charge | -2.1M | 0.00 | 0.00 | 0.00 | ||
| Interest Expense On Debt | 0.00 | 0.00 | 0.00 | 3.3M | ||
| Other Expenses | 967.0K | 5.6K | 14.4K | 0.00 | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -53.2M | -19.8M | -53.6M | -83.5M | |
| Net Income | -53.2M | -19.8M | -53.6M | -83.5M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 94.4M | 102.6M | 111.1M | 112.8M | |
| Shares To Calculate EPS Diluted | 94.4M | 102.6M | 111.1M | 112.8M | ||
| Earnings Per Share | EPS | -$0.56 | -$0.19 | -$0.48 | -$0.74 | |
| EPS Diluted | -$0.56 | -$0.19 | -$0.48 | -$0.74 | ||
.
